UBS Group’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,000
| Closed | -$2.4K | – | 9712 |
|
|
2025
Q1 | $2.4K | Buy |
2,000
+1,476
| +282% | +$1.77K | ﹤0.01% | 8022 |
|
|
2024
Q4 | $4.98K | Sell |
524
-293
| -36% | -$2.78K | ﹤0.01% | 7465 |
|
|
2024
Q3 | $14.2K | Buy |
817
+774
| +1,800% | +$13.4K | ﹤0.01% | 6341 |
|
|
2024
Q2 | $562 | Buy |
+43
| New | +$562 | ﹤0.01% | 7701 |
|
|
2024
Q1 | – | Sell |
-26
| Closed | -$2.12K | – | 8906 |
|
|
2023
Q4 | $2.12K | Buy |
+26
| New | +$2.12K | ﹤0.01% | 6947 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 7755 |
|
|
2023
Q1 | – | Sell |
-47
| Closed | -$7.35K | – | 9464 |
|
|
2022
Q4 | $7.35K | Buy |
47
+22
| +88% | +$3.44K | ﹤0.01% | 7712 |
|
|
2022
Q3 | $7K | Buy |
+25
| New | +$7K | ﹤0.01% | 7832 |
|
|
2022
Q1 | – | Sell |
-46
| Closed | -$39K | – | 9831 |
|
|
2021
Q4 | $39K | Buy |
+46
| New | +$39K | ﹤0.01% | 6061 |
|
|
2021
Q3 | – | Sell |
-16
| Closed | -$18K | – | 8955 |
|
|
2021
Q2 | $18K | Buy |
16
+4
| +33% | +$4.5K | ﹤0.01% | 6370 |
|
|
2021
Q1 | $14K | Buy |
+12
| New | +$14K | ﹤0.01% | 6667 |
|